info@marketresearchfuture.com   📞 +1 (855) 661-4441(US)   📞 +44 1720 412 167(UK)   📞 +91 2269738890(APAC)

Antiviral Drugs Market against Novel Diseases Surges in 2024

By Shubhendra Anand , 05 April, 2025

Antiviral drugs are expanding their market size in 2024. The demand for antiviral drug production will increase in 2024 due to the increasing rate of prevailing diseases. Globally, the growth rate of viral diseases is a driving factor in the pharmaceutical market. Further, consumer demand for antiviral drugs with fewer side effects is evolving in the pharmaceutical sector.

Surveys of 2024 report that globally, the antiviral drugs segment may reach USD 51.18 billion in 2024. Moreover, the global revenue may turn around USD 55.3 billion from 2024 to 2029. The antiviral drug market is anticipated to grow with an annual growth rate of 1.58 percent. The antiviral drugs market expects the highest revenue in the United States in 2024. Consumers have been looking for variations in antiviral drugs for the last two years. The antiviral drugs segment has experienced significant growth over the years. It is driven mainly toward the treatment of novel epidemics like COVID-19. Further, consumers seek antiviral drugs with minimal side effects for better consumption.

The global market for antiviral treatments is forecasted to grow substantially, bolstered mainly by Biktarvy, an anti-HIV medication released by Gilead in 2018. The drug maintained high revenues throughout the forecast period. These treatments will likely be making an annual revenue of USD55 billion by 2029, an 8 percent increase from the projected revenue in 2024. Approval has been granted for ORLADEYO (berotralstat) as prophylaxis for patients with hereditary angioedema (HAE). This dosage form is administered orally with a frequency of once a day and is approved for use in adult and pediatric patients aged twelve years and older. Moreover, the antiviral drug Paxlovid developed by Pfizer yielded good revenue in 2022 and 2023. Hence, the antiviral drugs market for novel epidemics is anticipated to grow in the upcoming years.

ANTIVIRAL-DRUGS-2024.jpg

Latest News

Mexico-Energy-Sector.jpg
Mexico Energy Sector aims to Expand Clean Energy Transition by 2030

Mexico is progressing rapidly in the renewable energy sector, envisioning double its production by 2030. By 2024, 35% of electricity should come from clean sources, compared to 29% in 2022. With a focus on solar, geothermal, wind, and hydroelectric…

Read More

-CLEANERGY-IN-US.jpg
With Surge in Nuclear Power, Texas Positions itself as Clean Energy Leader

Nuclear energy has been gaining traction in the global market, as have its requirements from big corporations. Texas has begun its revival phase as one of the front-runners in this new economic race. An expanding demand for nuclear energy…

Read More

SMR-2024.jpg
Small Nuclear Reactors may Help in the Progress of Clean Energy Transformation

A transformation is occurring globally in the pattern of energy sources with the rise of small nuclear reactors (SMRs) as the solution to clean, secure, and cost-effective energy. These power-efficient and small-sized reactors are becoming popular…

Read More

UK-FUEL-PRICE-2024.jpg
High Cost of Uk Gasoline Prices Fuels Debate

In the past few weeks, the fuel price in the UK has dropped a bit, but it is still expensive for drivers. From 143.15p per liter, unleaded gasoline primarily sells for 136.15p as of last week, while diesel has remained around 141p per Liter. However…

Read More

s-Leadership-in-Global-Oil-Imports.jpg
Asia's Leadership in Global Oil Imports: Consequences for the Automotive Sector in 2025

Asia has retained the position as the top oil importer in 2025, and continues to maintain that critical position in the energy sector that the world relies on. China has retained its top spot as the most prominent crude oil importer since 2013. The…

Read More

Author Pic
Shubhendra Anand

Head Research